Evista Oral Tablet 60Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Evista: Oral tablet (60mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_6592.JPG
Evista 60mg Tab
Eli Lilly and Co
Pill Identification: LILLY 4165 
Drug Image file DrugItem_6592.JPG
Evista 60mg Tab
Eli Lilly and Co
Pill Identification: LILLY 4165 

What is this Medicine?

RALOXIFENE (ral OX i feen) reduces the amount of calcium lost from bones. It is used to treat and prevent osteoporosis in women who have experienced menopause.

Similar Generic Drugs : Raloxifene: Oral tablet (60mg)
CVS Pharmacy Patient Statistics for Evista: Oral tablet(60mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Evista 60mg Tablet

NDC: 000024165
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Breast Cancer Prophylaxis, Osteoporosis Prophylaxis, Osteoporosis

Sometimes used for but not FDA approved for the following conditions:
Uterine Leiomyomata

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Evista 60mg Tablet
Drug Image file DrugItem_6592.JPG
Eli Lilly and Co
Pill Identification: LILLY 4165 
Shape: oval
Color: white
Drug Image file DrugItem_12380.JPG
Eli Lilly and Co
Pill Identification: LILLY 4165 
Shape: oval
Color: white

Reported Side Effects for Evista 60mg Tablet

Brain Attack Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
1.0-2.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
1.0-2.0%*
Severity: SEVERE
Onset: DELAYED
Gas Incidence:
1.3-3.1%*
Severity: MILD
Onset: EARLY
Hypoesthesia Incidence:
2.1%*
Severity: MILD
Onset: DELAYED
Conjunctivitis Incidence:
2.2%*
Severity: MODERATE
Onset: DELAYED
Inflamed Vocal Cords Incidence:
2.2%*
Severity: MILD
Onset: DELAYED
Fainting Incidence:
2.3%*
Severity: MILD
Onset: EARLY
Migraine Incidence:
2.4%*
Severity: MODERATE
Onset: EARLY
Nerve Pain Incidence:
2.4%*
Severity: MODERATE
Onset: DELAYED
Vaginal Bleeding Incidence:
2.5-6.2%*
Severity: MODERATE
Onset: DELAYED
Excessive Sweating Incidence:
2.5-3.1%*
Severity: MILD
Onset: DELAYED
Chest Pain Incidence:
2.8-4.0%*
Severity: MODERATE
Onset: EARLY
Fever Incidence:
3.1-3.9%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
3.3-14.1%*
Severity: MODERATE
Onset: DELAYED
Vaginal Discharge Incidence:
3.3%*
Severity: MILD
Onset: DELAYED
Gallstones Incidence:
3.3%*
Severity: MODERATE
Onset: DELAYED
Bladder Infection Incidence:
3.3-4.6%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
3.4-4.8%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
4.1%*
Severity: MILD
Onset: EARLY
Vaginal Infection Incidence:
4.3%*
Severity: MODERATE
Onset: DELAYED
Breast Pain Incidence:
4.4%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
5.3-7.6%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
5.5%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
5.5%*
Severity: MILD
Onset: EARLY
Muscle Cramps Incidence:
5.9-12.1%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
5.9%*
Severity: MILD
Onset: EARLY
Cough Incidence:
6.0-9.3%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
6.4%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
6.6%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
7.2%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
7.7%*
Severity: MILD
Onset: EARLY
Hot Flashes Incidence:
7.8-28.7%*
Severity: MODERATE
Onset: DELAYED
Sinus Infection Incidence:
7.9-10.3%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
8.8%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
9.2%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
9.7-24.6%*
Severity: MILD
Onset: EARLY
Rhinitis Incidence:
10.2%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
10.7-15.5%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
11.0-15.1%*
Severity: MILD
Onset: DELAYED
Flu Incidence:
13.5-14.6%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Evista

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5